National Health Investors, Inc. (NYSE:NHI) Given Consensus Rating of “Moderate Buy” by Brokerages

National Health Investors, Inc. (NYSE:NHI) has earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $87.50.

A number of equities research analysts have recently weighed in on NHI shares. Truist Financial lowered their price target on National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Wells Fargo & Company lowered their price objective on shares of National Health Investors from $86.00 to $84.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 22nd. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th.

National Health Investors Price Performance

NHI opened at $73.46 on Friday. National Health Investors has a 1-year low of $68.80 and a 1-year high of $91.38. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The company has a market capitalization of $3.56 billion, a P/E ratio of 23.70, a PEG ratio of 3.82 and a beta of 0.55. The company has a 50-day moving average of $79.59 and a 200-day moving average of $80.54.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The firm had revenue of $115.13 million during the quarter, compared to the consensus estimate of $70.22 million. During the same quarter last year, the firm posted $1.15 earnings per share. National Health Investors’s revenue was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities analysts expect that National Health Investors will post 5.07 EPS for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.0%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s dividend payout ratio is currently 118.71%.

Institutional Investors Weigh In On National Health Investors

Institutional investors have recently modified their holdings of the business. International Assets Investment Management LLC bought a new position in National Health Investors during the 4th quarter worth $27,000. EverSource Wealth Advisors LLC grew its stake in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new position in National Health Investors during the 4th quarter worth $33,000. GAMMA Investing LLC grew its stake in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 136 shares during the last quarter. Finally, Key Capital Management INC bought a new position in National Health Investors during the 4th quarter worth $47,000. Institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.